Chennai Meenakshi Multispeciality Hospital Ltd
BSE:523489
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
29.36
55.93
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Chennai Meenakshi Multispeciality Hospital Ltd
Revenue
Chennai Meenakshi Multispeciality Hospital Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Chennai Meenakshi Multispeciality Hospital Ltd
BSE:523489
|
Revenue
₹347.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Revenue
₹217.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Revenue
₹84.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Revenue
₹79.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Revenue
₹58.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Revenue
₹36.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Chennai Meenakshi Multispeciality Hospital Ltd
Glance View
Chennai Meenakshi Multispeciality Hospital Ltd. operates as a hospital, which provides healthcare services. The company is headquartered in Chennai, Tamil Nadu. The firm operates an approximately 100-bedded hospital located at Mylapore. The firm's services include cardiology, cosmetic and plastic surgery, diabetology, endocrinology, dermatology, dentistry, surgical gastroenterology, general surgery, gynecology, vascular surgery, minimal access general and metabolic tumors surgery, neurology, neuro surgery, orthopedics, pediatrics, pediatric gastroenterology, ophthalmology and pulmonology. The company also offers a range of programs, such as Basic Health Check Up, which include hematology and bio-chemistry; Master Health Check Up, which include hematology, bio-chemistry, lipid profile, general tests and liver function test (LFT), and Executive Health Check Up, which include hematology, bio-chemistry, renal profile, lipid profile, LFT and general tests.
See Also
What is Chennai Meenakshi Multispeciality Hospital Ltd's Revenue?
Revenue
347.2m
INR
Based on the financial report for Jun 30, 2025, Chennai Meenakshi Multispeciality Hospital Ltd's Revenue amounts to 347.2m INR.
What is Chennai Meenakshi Multispeciality Hospital Ltd's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Chennai Meenakshi Multispeciality Hospital Ltd have been 10% over the past three years , 9% over the past five years , and 6% over the past ten years .